Draft guidance recommends pomalidomide (Imnovid, Celgene)

NICE has published draft guidance recommending pomalidomide (Imnovid, Celgene) for treating some people with multiple myeloma.  New data, including updated comparisons of pomalidomide with other treatments, was presented as part of this review. The committee concluded that pomalidomide could be recommended as a clinically and cost effective use of NHS resources in people whose disease…

Read More

Women and Homelessness: A Health Overview

Women and Homelessness: A Health Overview Peggy Maguire and Kristin Semancik European Institute of Women’s Health Women and their children are the fastest growing group within the homeless community. Yet, there is a lack of information on and understanding of homeless women and families, particularly about their health status and healthcare needs, facing many health…

Read More

Women’s Health in Europe – research to health care delivery

Women’s Health in Europe – research to health care delivery Presented by: Peggy Maguire, Director General, European Institute of Women’s Health and Chaired by Theresa Fyffe Given at the Churchill Auditorium (main hall) 12.30, Wed 23rd November 2016 at the RCN International Centenary Conference The presentation can be downloaded from here        …

Read More

Pancreatic cancer drug not recommended

Pancreatic cancer drug not recommended People with pancreatic cancer have very limited treatment options. HIgh costs of pegylated liposomal irinotecan means it is too expensive to recommend. said NICE (National Institute for Health and Care Excellence) as given in their draft guidance not recommending pegylated liposomal irinotecan also called nal-iri, Onivyde and made by Shire),…

Read More

People with Mild Cognitive Impairment may need strength through exercise

Strength training can benefit people with Mild Cognitive Impairment (MCI) Increased muscle strength leads to improved brain function in adults with Mild Cognitive Impairment (MCI), recent trial results led by University of Sydney reveal.135 million people are forecast to suffer from dementia by 2050, so the study’s findings in the Journal of American Geriatrics has…

Read More